Air Transport Services (ATSG) Up 0.3% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194341/air-transport-services-atsg-up-0-3-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194341
Dec 06, 2023 - Air Transport Services (ATSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
SentinelOne (S) Q3 Earnings Beat Estimates, Revenues Up Y/Y
https://www.zacks.com/stock/news/2194283/sentinelone-s-q3-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2194283
Dec 06, 2023 - SentinelOne (S) third-quarter 2024 results reflect improved revenues driven by strong demand for its AI solutions.
0
4 Stocks With Impressive Interest Coverage Ratio to Snap Up
https://www.zacks.com/stock/news/2194265/4-stocks-with-impressive-interest-coverage-ratio-to-snap-up?cid=CS-ZC-FT-analyst_blog|rw-2194265
Dec 06, 2023 - A company that is capable of generating earnings well above its interest expense can withstand financial hardship. EG, MOD, STRL and PG are sound enough to meet financial obligations.
0
CTO Realty (CTO) Sells Assets, Ups Financial Strength, Stock Up
https://www.zacks.com/stock/news/2194261/cto-realty-cto-sells-assets-ups-financial-strength-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2194261
Dec 06, 2023 - CTO Realty's (CTO) latest dispositions showcase the company's commitment to enhancing its financial position and focusing on core assets.
0
Radian Group (RDN) Up 39.8% in a Year: More Room for Growth?
https://www.zacks.com/stock/news/2194041/radian-group-rdn-up-39-8-in-a-year-more-room-for-growth?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2194041
Dec 06, 2023 - Radian Group (RDN) stock rallies on the back of improved persistency and mortgage insurance portfolio, robust capital position as well as prudent capital deployment.
0
Syros Presents Positive Phase 2 Trial Data Of Tamibarotene Combination: Stock Up In Premarket
https://www.rttnews.com/story.aspx?Id=3409889
Dec 06, 2023 - Syros Pharmaceuticals (SYRS) announced Wednesday positive initial data from its ongoing SELECT-AML-1 Phase 2 trial evaluating tamibarotene, in combination with venetoclax and azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia or AML and RARA gene overexpression.
0
Lawmakers ramp up scrutiny of Shein, call for proof it doesn't use forced labor after retailer files for IPO
https://www.cnbc.com/2023/12/05/shein-ipo-lawmakers-scrutinize-forced-labor.html
Dec 05, 2023 - Lawmakers are ramping up their scrutiny of Shein and calling for proof it doesn't use forced labor after the retailer confidentially filed to go public.
0
Jefferies (JEF) Strengthens Canada Presence, Sets Up IB Unit
https://www.zacks.com/stock/news/2193819/jefferies-jef-strengthens-canada-presence-sets-up-ib-unit?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2193819
Dec 05, 2023 - Jefferies (JEF) strengthens its footprint in Canada with the new investment banking unit.
0
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
https://www.zacks.com/stock/news/2193796/alterity-athe-up-on-preclinical-parkinson-s-treatment-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193796
Dec 05, 2023 - Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
0
GMS Gears Up to Report Q2 Earnings: Will It Disappoint?
https://www.zacks.com/stock/news/2193793/gms-gears-up-to-report-q2-earnings-will-it-disappoint?cid=CS-ZC-FT-analyst_blog|earnings_preview-2193793
Dec 05, 2023 - Low steel prices and high costs are likely to be reflected in GMS' fiscal Q2 performance.
0